A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
Copyright policy )A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
EK1 is a broad-spectrum human coronavirus fusion inhibitor for combating infection of current and emerging coronaviruses.
- New York Blood Center United States
- Scripps Research Institute United States
- Shanghai University China (People's Republic of)
- The University of Texas Medical Branch at Galveston United States
- ShanghaiTech University China (People's Republic of)
Models, Molecular, Protein Conformation, Membrane Fusion, Cell Line, Coronavirus, Disease Models, Animal, Mice, Protein Domains, Solubility, Spike Glycoprotein, Coronavirus, Animals, Humans, Protein Interaction Domains and Motifs, Amino Acid Sequence, Coronavirus Infections, Peptides, Research Articles, Phylogeny, Viral Fusion Protein Inhibitors
Models, Molecular, Protein Conformation, Membrane Fusion, Cell Line, Coronavirus, Disease Models, Animal, Mice, Protein Domains, Solubility, Spike Glycoprotein, Coronavirus, Animals, Humans, Protein Interaction Domains and Motifs, Amino Acid Sequence, Coronavirus Infections, Peptides, Research Articles, Phylogeny, Viral Fusion Protein Inhibitors
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).431 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 0.1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 1% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 0.1%
Citations provided by BIP!Popularity provided by BIP!